Internal Medicine · Saint Louis, MO
NPI
1457354276
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2340 Hampton Ave
Saint Louis, MO, 63139
Phone (314) 647-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$219K
8,188 services
Medicare patients, 2024
323
Average age 69
Drug cost, 2024
$7.5M
14,165 prescriptions
Company payments, 2025
$29K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Prelutsky was code 36415 (venipuncture blood collection), 699 times for 277 patients. In total David J Prelutsky billed 8,188 services in 78 codes, and Medicare paid $219K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 699 | 277 | $8.59 | $6,003 |
| 99214 Office E&M - Established | Office | 579 | 258 | $86.27 | $50K |
| 99215 Office E&M - Established | Office | 346 | 158 | $123.77 | $43K |
| 90480 Vaccine Administration | Office | 285 | 186 | $41.33 | $12K |
| 91320 Vaccine Product | Office | 274 | 184 | $139.96 | $38K |
| 83036 Blood Count | Office | 199 | 105 | $9.43 | $1,876 |
| G0008 Administration of influenza virus vaccine | Office | 168 | 145 | $31.21 | $5,243 |
| 81002 Clinical Chemistry | Office | 167 | 132 | $3.35 | $559 |
| 71046 X-ray - Chest | Office | 146 | 128 | $24.37 | $3,558 |
| 90656 Vaccine Product | Office | 146 | 146 | $21.60 | $3,154 |
| 93000 Electrocardiogram | Office | 134 | 122 | $10.81 | $1,449 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 119 | 95 | $12.80 | $1,523 |
| 99421 Office/Outpatient Services | Office | 100 | 79 | $12.10 | $1,210 |
| 99211 Office E&M - Established | Office | 99 | 61 | $17.87 | $1,769 |
| 96372 Injection Administration | Office | 86 | 31 | $10.14 | $872 |
By year: 2022 $172K for 7,057 services; 2023 $167K for 9,498 services; 2024 $219K for 8,188 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 699 | 277 | $8.59 | $6,003 |
| 83036 Blood Count | 199 | 105 | $9.43 | $1,876 |
| 81002 Clinical Chemistry | 167 | 132 | $3.35 | $559 |
| 82270 Immunoassay | 86 | 86 | $4.19 | $360 |
| 81003 Clinical Chemistry | 20 | 17 | $2.20 | $44 |
Medicare prescription drug claims, 2024
In 2024, the drug David J Prelutsky prescribed most often to Medicare patients was Atorvastatin Calcium, with 665 prescriptions and refills. In total David J Prelutsky wrote 14,165 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 665 | 1,705 | 168 | $4,705 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 589 | 614 | 59 | $2.6M |
| Lisinopril Generic | 432 | 1,011 | 100 | $2,382 |
| Duloxetine Hcl Generic | 373 | 650 | 75 | $8,657 |
| Alprazolam Generic | 354 | 388 | 56 | $2,412 |
| Pantoprazole Sodium Generic | 342 | 741 | 80 | $3,076 |
| Losartan Potassium Generic | 297 | 741 | 68 | $2,346 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 275 | 275 | 45 | $9,796 |
| Gabapentin Generic | 256 | 399 | 57 | $3,650 |
| Descovy Emtricitabine/Tenofov Alafenam | 245 | 247 | 23 | $594K |
| Rosuvastatin Calcium Generic | 238 | 559 | 56 | $3,144 |
| Doxazosin Mesylate Generic | 234 | 514 | 48 | $2,322 |
| Metoprolol Succinate Generic | 231 | 625 | 63 | $2,727 |
| Pifeltro Doravirine | 224 | 232 | 24 | $433K |
| Trazodone Hcl Generic | 219 | 437 | 46 | $2,359 |
Brand drugs: 3,352 claims; generic drugs: 10,775 claims; opioid claims: 922.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Prelutsky $29K ($29K in general payments such as food, travel and fees) from 29 companies. The largest payer was Gilead Sciences, Inc. with $26K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 56 | $26K |
| ViiV Healthcare Company GSK | 33 | $626 |
| Pfizer Inc. PFE | 21 | $258 |
| Napo Pharmaceuticals Inc | 10 | $203 |
| Abbvie Inc. ABBV | 9 | $192 |
| Merck Sharp & Dohme LLC MRK | 7 | $184 |
| Novo Nordisk Inc NVO | 9 | $155 |
| Theratechnologies Inc. THTX | 4 | $102 |
| Abbott Laboratories ABT | 4 | $94.72 |
| Lilly USA, LLC LLY | 4 | $77.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.